Aleksandra Gruevska
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Altered Sphingolipid Metabolism is Associated with Osimertinib Resistance in Nonsmall-Cell Lung Cancer.
Journal: Journal of proteome research
Published: April 16, 2026
High-Throughput Proteomics Sample Preparation Using a 96-Channel Pipettor and Magnetic Pin Device.
Journal: Journal of proteome research
Published: February 16, 2026
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.
Journal: Nature cell biology
Published: September 10, 2025
Reply to: "Unraveling sphingolipid complexity in liver fibrosis: Perspectives for future research".
Journal: Metabolism: clinical and experimental
Published: April 10, 2025
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver.
Journal: Metabolism: clinical and experimental
Published: January 13, 2025
Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2023
Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less.
Journal: Cell death & disease
Published: August 15, 2021
Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?
Journal: The Journal of pathology
Published: February 02, 2021
Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment.
Journal: Cells
Published: December 26, 2020
p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors.
Journal: Antiviral research
Published: December 28, 2019
Last Updated: 09/26/2026